WntRx Pharmaceuticals develops non-toxic selective drugs for the treatment of patients with colorectal cancer and critical unmet medical needs. It specializes in the development of oncogenic-specific inhibitors of Wnt signaling, a pathway aberrantly activated in a multitude of cancers. The company was founded in 2013 and is headquartered in Boston, Massachusetts.
View Top Employees from WntRx Pharmaceuticals| Website | http://www.wntrxpharm.com/ |
| Revenue | $4 million |
| Employees | 3 (0 on RocketReach) |
| Founded | 2013 |
| Address | 700 Main St, Cambridge, Massachusetts 02139, US |
| Phone | (617) 863-3696 |
| Technologies |
JavaScript,
HTML,
Microsoft Outlook
+3 more
(view full list)
|
| Industry | Biotechnology, Manufacturing General, Manufacturing, Science and Engineering, Health Care, Medical, Pharmaceutical |
| Competitors | Frost Biologic, Genzada Pharmaceuticals USA, Inc, SynDevRx, Inc. |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular WntRx Pharmaceuticals employee's phone or email?
WntRx Pharmaceuticals Questions
The WntRx Pharmaceuticals annual revenue was $4 million in 2024.
WntRx Pharmaceuticals is based in Cambridge, Massachusetts.
The NAICS codes for WntRx Pharmaceuticals are [3254, 325, 32, 32541].
The SIC codes for WntRx Pharmaceuticals are [283, 28].
Related Companies
